A randomized controlled trial of cognitive remediation for a national cohort of forensic patients with schizophrenia or schizoaffective disorder

Abstract

BackgroundEvidence is accumulating that Cognitive Remediation Training (CRT) is effective for ameliorating cognitive deficits experienced by patients with schizophrenia and accompanying functional impairment. There has been no randomized controlled trial of CRT using a nationally representative population of forensic patients, despite the significant cognitive deficits frequently present within this group.MethodsSixty-five patients with schizophrenia or schizoaffective disorder were enrolled in a single blind randomized controlled trial of CRT versus treatment as usual (TAU); representing 94% of those eligible within a national forensic cohort. The primary outcome measure was the composite score of the MATRICS Consensus Cognitive Battery (MCCB). Secondary outcome measures included neurocognitive and social cognitive domains, symptoms, and ‘real world’ functioning. Patient satisfaction was examined using an exit interview. Participants were reassessed at 8 months follow up. All data were analyzed using an intention to treat design (ITT).ResultsFor the primary outcome measure, the MCCB composite score, there were significant differences between those who participated in CRT and those receiving TAU at both end of treatment and 8 months follow up (Cohen’s d = 0.34. Significant improvements were observed in visual and working memory. Mediation analysis found that those who cognitively benefited from CRT had corresponding improved functioning, and more net positive therapeutic moves i.e. moves to units with lower security within the hospital. Ninety-six percent believed their cognitive gains positively affected their daily lives.ConclusionsCRT may be an acceptable and efficacious intervention for forensic patients with schizophrenia or schizoaffective disorder.Trial registrationClinicalTrials.gov Identifier: NCT02360813. Trial registered Feb 4th 2015, last updated May 1st 2015.

Brain-Derived Neurotrophic Factor: A Key Molecule for Memory in the Healthy and the Pathological Brain

“…Moreover, BDNF concentration positively correlated with cognitive performance in a RBANS scale of memory. Not only the pharmacological interventions were effective on the reduction of mnemonic symptoms, different cognitive training protocols were also designed to enhance specific cognitive domains, especially memory (Guimond et al, 2018; O’Reilly et al, 2019). Fisher et al (2016) conducted a computerized cognitive training in SZ patients and the patients exposed to this program present higher levels of sBDNF compared to the control group.…”

Cognitive remediation for severe mental illness: state of the field and future directions

“…As the field continues to grow, with several treatment programs available, health care decision makers who wish to bring cognitive remediation to the clinic should be encouraged that, although this treatment requires training and staff time, the cost‐benefit analysis is favorable. Studies of cognitive remediation have systematically reported on how this trade‐off affects quality of life and financial burden associated with cognitive impairment, with evidence supporting higher rates of employment, reduced job stress, and lower institutional treatment demands.…”

Implementation of a specialized program to treat violence in a forensic population

“…40 Cognitive rehabilitation has been utilized to treat neurocognitive and neurodevelopmental disorders to increase functioning. In a study of cognitive rehabilitation in forensic patients, O'Reilly and colleagues 41 supported the use of cognitive rehabilitation interventions to improve several cognitive functions and reduce risk (eg, moved to lower security unit). Persons with schizophrenia often display social deficits.…”